Conference · Medicine & Health
AACR Special Conference in Cancer Research: Advances in the Pathogenesis and Immune Therapies of Liver Cancer
AACR Special Conference in Cancer Research: Advances in the Pathogenesis and Immune Therapies of Liver Cancer overview
In short
AACR Special Conference in Cancer Research: Advances in the Pathogenesis and Immune Therapies of Liver Cancer is a conference on medicine & health taking place in Austin, United States, from 6–8 Dec 2026. It is organised by American Association for Cancer Research (AACR).
About this event
Select "Patients / Caregivers / Public" or "Researchers / Professionals" to filter your results. To further refine your search, toggle appropriate sections on or off.
Home > Cancer Researchers / Other Health Care Professionals > Meetings > Meeting > AACR Special Conference in Cancer Research: Advances in the Pathogenesis and Immune Therapies of Liver Cancer
Richard S. Finn, UCLA Jonsson Comprehensive Cancer Center, Santa Monica, California Josep M. Llovet, Icahn School of Medicine at Mount Sinai, New York, New York Jessica Zucman-Rossi, Cordeliers Research Center at INSERM, Paris, France
Liver cancer remains a major global health challenge and is now among the leading causes of cancer-related mortality worldwide. By 2026, liver cancer is estimated to affect over one million individuals annually, with incidence continuing to rise, particularly in high-risk and underserved populations. Despite significant advances in our understanding of disease biology and therapeutic development, most patients with liver cancer still present at advanced stages, limiting curative options and contributing to suboptimal outcomes.
This second program brings together international leaders in liver cancer research and clinical care to address critical gaps in knowledge and management across disease subtypes. The meeting will explore the molecular pathogenesis and risk factors driving hepatocellular carcinoma (HCC), the evolving role of immunotherapies in early, intermediate, and advanced HCC, and emerging molecular and immune-based treatment strategies. Dedicated sessions will also focus on the molecular pathogenesis and therapies for cholangiocarcinoma, as well as health disparities, pediatric liver tumors, and the patient advocacy perspective.
Across plenary sessions, speakers will examine the contributions of the tumor microenvironment, immune modulation, and the microbiome to liver cancer development and progression. Additional emphasis will be placed on mechanisms of action of current therapies, predictive biomarkers, innovative clinical trial design, liquid biopsy approaches, and the scientific rationale for future therapeutic combinations.
Quick answers
When is AACR Special Conference in Cancer Research: Advances in the Pathogenesis and Immune Therapies of Liver Cancer?
It takes place from 6–8 Dec 2026.
Where is AACR Special Conference in Cancer Research: Advances in the Pathogenesis and Immune Therapies of Liver Cancer held?
In Austin, United States.
Who organises AACR Special Conference in Cancer Research: Advances in the Pathogenesis and Immune Therapies of Liver Cancer?
American Association for Cancer Research (AACR).
Listed by the organizer on 16 Nov 2026. Check dates and fees on the official website before booking travel. Report a problem with this listing.